4.71 -0.30 (-5.99%)
SNTS
| Trade SNTS now with |
|
Stock Details
Last Trade:4.71 Change:-0.30 (-5.99%) Prev Close:5.01 Open: 5.01 Days Range:4.64 – 5.02 52 Week Range: 2.40 - 5.10 Volume:419389 P/E: 471.00EPS:0.01
View AllRecent Alerts 02/09/12
Recent Alert on 12/21/11 at 4:09pm
Santarus (SNTS) Enters Agreement to Commercialize FENOGLIDE(R) in US; Offers FY12 Sales Guidance
Santarus (SNTS) Enters Agreement to Commercialize FENOGLIDE(R) in US; Offers FY12 Sales Guidance
Santarus (Nasdaq: SNTS) entered an exclusive license agreement with Short Therapeutics to commercialize FENOGLIDE(R) Tablets 40mg, 120mg in the US. Under the terms of the license agreement, Santarus will pay Shore an $11 million upfront fee and... Read More
Recent Alert on 12/21/11 at 4:09pm
Santarus (SNTS) Enters Agreement to Commercialize FENOGLIDE(R) in US; Offers FY12 Sales Guidance
Santarus (SNTS) Enters Agreement to Commercialize FENOGLIDE(R) in US; Offers FY12 Sales Guidance
View AllRecent Press Releases
Press Release on 02/06/12 at 4:00am
Santarus Begins Promoting Cholesterol-Lowering Product FENOGLIDE
Santarus Begins Promoting Cholesterol-Lowering Product FENOGLIDE
View AllRecent SEC Filings
View AllRecent Blog Posts
Blog Posts on 12/22/11 at 12:30pm
Santarus' CEO Discusses Business Update Conference Call Transcript
Santarus' CEO Discusses Business Update Conference Call Transcript
Blog Posts on 12/02/11 at 11:58am
Santarus' CEO Discusses at Lazard Capital Markets 8th Annual Healthcare - Conference Call Transcript
Santarus' CEO Discusses at Lazard Capital Markets 8th Annual Healthcare - Conference Call Transcript